These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
566 related articles for article (PubMed ID: 10319384)
1. Treatment of hairy-cell leukemia: current views. Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384 [TBL] [Abstract][Full Text] [Related]
2. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine). Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889 [TBL] [Abstract][Full Text] [Related]
3. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine. Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616 [TBL] [Abstract][Full Text] [Related]
4. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy]. Rucińska M; Machaczka M; Załuska A; Skotnicki AB Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885 [TBL] [Abstract][Full Text] [Related]
5. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse. Tallman MS; Hakimian D; Kopecky KJ; Wheaton S; Wollins E; Foucar K; Cassileth PA; Habermann T; Grever M; Rowe JM; Peterson LC Clin Cancer Res; 1999 Jul; 5(7):1665-70. PubMed ID: 10430066 [TBL] [Abstract][Full Text] [Related]
6. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years. Else M; Ruchlemer R; Osuji N; Del Giudice I; Matutes E; Woodman A; Wotherspoon A; Swansbury J; Dearden C; Catovsky D Cancer; 2005 Dec; 104(11):2442-8. PubMed ID: 16245328 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study. Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049 [TBL] [Abstract][Full Text] [Related]
8. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)]. Pawelski S Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218 [TBL] [Abstract][Full Text] [Related]
9. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications. Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine. Jehn U; Bartl R; Dietzfelbinger H; Vehling-Kaiser U; Wolf-Hornung B; Hill W; Heinemann V Ann Hematol; 1999 Mar; 78(3):139-44. PubMed ID: 10211756 [TBL] [Abstract][Full Text] [Related]
14. Phase II trials of pentostatin (Nipent) in hairy cell leukemia. Kraut EH Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA). Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521 [TBL] [Abstract][Full Text] [Related]
16. [Successful ambulatory treatment of patients with hairy-cell leukemia using one cycle of the purine analog cladribine. 'Hemato-oncologic volwassen Nederland' (HOVON) Study Group]. Raemaekers JM; van 't Veer MB; Bogman MJ Ned Tijdschr Geneeskd; 1996 Aug; 140(31):1600-4. PubMed ID: 8768814 [TBL] [Abstract][Full Text] [Related]
17. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients. Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659 [TBL] [Abstract][Full Text] [Related]
18. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up. Seymour JF; Talpaz M; Kurzrock R Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417 [TBL] [Abstract][Full Text] [Related]
19. Pentostatin: impact on outcome in hairy cell leukemia. Grever MR Hematol Oncol Clin North Am; 2006 Oct; 20(5):1099-108. PubMed ID: 16990110 [TBL] [Abstract][Full Text] [Related]
20. Current treatment options in hairy cell leukemia and hairy cell leukemia variant. Robak T Cancer Treat Rev; 2006 Aug; 32(5):365-76. PubMed ID: 16781083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]